{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:40:37Z","timestamp":1772548837163,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":8320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1038\/modpathol.3880078","type":"journal-article","created":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T12:57:28Z","timestamp":1081947448000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Immunoreactivity with the Anti-MAGE Antibody 57B in Malignant Melanoma: Frequency of Expression and Correlation with Prognostic Parameters"],"prefix":"10.1016","volume":"13","author":[{"given":"Klaus J","family":"Busam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Berwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilio C","family":"Spagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd J","family":"Old","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim A","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.3880078_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0952-7915(97)80049-0","article-title":"Tumor antigens","volume":"9","author":"Boon","year":"1997","journal-title":"Cur Opin Immunol"},{"key":"10.1038\/modpathol.3880078_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.183.3.725","article-title":"Human tumor antigens recognized by T lymphocytes","volume":"183","author":"Boon","year":"1996","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.3880078_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-065X.1995.tb00084.x","article-title":"Genes coding for tumor antigens recognized by cytolytic T lymphocytes","volume":"145","author":"Van Pel","year":"1995","journal-title":"Immunol Rev"},{"key":"10.1038\/modpathol.3880078_bib4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"Van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1038\/modpathol.3880078_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00185107","article-title":"Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes","volume":"53","author":"Traversari","year":"1992","journal-title":"Immunogenetics"},{"key":"10.1038\/modpathol.3880078_bib6","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1002\/eji.1830241218","article-title":"A peptide induced by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3","volume":"24","author":"Van der Bruggen","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1038\/modpathol.3880078_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF01246677","article-title":"Structure, chromosomal localization, and expression of 12 genes of the MAGE family","volume":"40","author":"De Plaen","year":"1994","journal-title":"Immunogenetics"},{"key":"10.1038\/modpathol.3880078_bib8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.179.3.921","article-title":"Human gene MAGE-3 codes for antigen recognized on a melanoma by autologous cytolytic T lymphocytes","volume":"179","author":"Gaugler","year":"1994","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.3880078_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.182.3.689","article-title":"A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on human melanoma","volume":"182","author":"Van den Eynde","year":"1995","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.3880078_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910630313","article-title":"Expression of MAGE genes in primary and metastatic cutaneous melanoma","volume":"63","author":"Brasseur","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.3880078_bib11","first-page":"743","article-title":"Identification of a new MAGE gene with tumor-specific expression by representational difference analysis","volume":"58","author":"Lucas","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3880078_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/(SICI)1097-0215(19980302)75:5<762::AID-IJC16>3.0.CO;2-8","article-title":"MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus","volume":"75","author":"Jurk","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.3880078_bib13","first-page":"2236","article-title":"Identification and intracellular location of MAGE-3 gene product","volume":"55","author":"Kocher","year":"1995","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3880078_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1097-0215(19981029)78:3<387::AID-IJC22>3.0.CO;2-2","article-title":"Expression of multiple cancer\/testis antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies","volume":"78","author":"Sahin","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.3880078_bib15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ijc.2910560612","article-title":"Expression of MAGE genes by non-small cell lung carcinomas","volume":"56","author":"Weynants","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.3880078_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000658-199608000-00011","article-title":"Expression of MAGE genes in human colorectal carcinoma","volume":"224","author":"Mori","year":"1996","journal-title":"Ann Surg"},{"key":"10.1038\/modpathol.3880078_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ijc.2910640112","article-title":"Expression of MAGE genes in transitional cell carcinomas of the urinary bladder","volume":"64","author":"Patard","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.3880078_bib18","first-page":"1549","article-title":"MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma","volume":"151","author":"Hofbauer","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.3880078_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ijc.2910630622","article-title":"Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3","volume":"63","author":"Marchand","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.3880078_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00008390-199602000-00003","article-title":"New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines","volume":"6","author":"Maeurer","year":"1996","journal-title":"Melanoma Res"},{"key":"10.1038\/modpathol.3880078_bib21","first-page":"754","article-title":"Melanoma-associated tumor antigens and their clinical relevance to immunotherapy","volume":"23","author":"Gattoni-Celli","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1038\/modpathol.3880078_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.med.47.1.481","article-title":"The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens","volume":"47","author":"Rosenberg","year":"1996","journal-title":"Annu Rev Med"},{"key":"10.1038\/modpathol.3880078_bib23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional area and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"key":"10.1038\/modpathol.3880078_bib24","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.3880078_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/1097-0142(19850715)56:2<413::AID-CNCR2820560234>3.0.CO;2-T","article-title":"The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51\u20133.99 mm","volume":"56","author":"Elder","year":"1985","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3880078_bib26","first-page":"103","article-title":"Malignant tumors (melanomas and related lesions","author":"Elder","year":"1990","journal-title":"Melanocytic tumors of the skin. Atlas of Tumor Pathology"},{"key":"10.1038\/modpathol.3880078_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0046-8177(86)80032-6","article-title":"The biologic forms of malignant melanoma","volume":"17","author":"Clark","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3880078_bib28","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/1097-0142(197312)32:6<1446::AID-CNCR2820320623>3.0.CO;2-8","article-title":"The classification of malignant melanoma and its histologic reporting","volume":"32","author":"McGovern","year":"1973","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3880078_bib29","unstructured":"American Joint Committee on Cancer. Manual for staging of cancer (4th ed.), Philadelphia: J.B. Lippincott; 1992. pp. 143\u2013148."},{"key":"10.1038\/modpathol.3880078_bib30","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1073\/pnas.95.12.6919","article-title":"Identification of multiple cancer\/testis antigens by allogeneic antibody screening of a melanoma cell line library","volume":"95","author":"Chen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/modpathol.3880078_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ijc.2910640505","article-title":"Peptide-specific CTL in tumor-infiltrating lymphocytes from metastatic melanomas expression MART-1\/Melan-A, gp100 and tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients","volume":"65","author":"Spagnoli","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.3880078_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000478-199801000-00007","article-title":"Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other steroid tumors","volume":"22","author":"Busam","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.3880078_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/00000478-199808000-00007","article-title":"Expression of Melan-A (MART-1) in benign melanocytic nevi and primary malignant melanoma","volume":"22","author":"Busam","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.3880078_bib34","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1073\/pnas.92.18.8125","article-title":"Immunophenotyping of melanomas for tyrosinase: implications for vaccine development","volume":"92","author":"Chen","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/modpathol.3880078_bib35","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1073\/pnas.93.12.5915","article-title":"Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas","volume":"93","author":"Chen","year":"1996","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1038\/modpathol.3880078_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000478-199805000-00011","article-title":"A103\u2013an anti-Melan-A\/MART-1 monoclonal antibody for the detection of malignant melanoma in paraffin embedded tissues","volume":"22","author":"Jungbluth","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.3880078_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1097-0215(19980717)77:2<200::AID-IJC5>3.0.CO;2-U","article-title":"High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A\/MART-1 gene expression in clusters of multiple cutaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies","volume":"77","author":"Dalerba","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.3880078_bib38","first-page":"341","article-title":"Lymphocytic infiltration and survival in malignant melanoma","author":"McGovern","year":"1981","journal-title":"Pathology of malignant melanoma: Masson monographs in dermatopathology"},{"key":"10.1038\/modpathol.3880078_bib39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9610(74)90275-X","article-title":"Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck","volume":"128","author":"Mansen","year":"1974","journal-title":"Am J Surg"},{"key":"10.1038\/modpathol.3880078_bib40","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3880078_bib41","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/bjc.1996.420","article-title":"Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon treatment","volume":"74","author":"Hakansson","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3880078_bib42","first-page":"43","article-title":"Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histologic prognostic indicator and an expression of local immune response","volume":"74","author":"Mihm","year":"1996","journal-title":"Lab Invest"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3880078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3880078","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222040595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222040595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3880078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:16:03Z","timestamp":1760231763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222040595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S0893395222040595"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.3880078","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoreactivity with the Anti-MAGE Antibody 57B in Malignant Melanoma: Frequency of Expression and Correlation with Prognostic Parameters","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3880078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2000 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}